SB 91: Syringe exchange program.
SB 91 status: Introduced — Public Law 144 (updated Mar 10, 2026).
What this bill does
Overall score
Bill summary
OfficialProhibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a quali...
Key analysis
Impact analysis
Environment
Benefits
- no material direct effect identified
Risks
- no material direct effect identified
Economy
Benefits
- no material direct effect identified
Risks
- no material direct effect identified
Society
Benefits
- extends state authorization of syringe programs to 2031
- strengthens regulatory oversight and complaint investigation
Risks
- 1,000-foot buffer zones may restrict site accessibility
- prohibition on chemical reagents may limit specific program utility
How trustworthy & consequential it is
Source
OpenStates
Confidence
lowlow
Analysis status
OpenStates summary
LegiScan returned a PDF-only document. PDF extraction is not enabled in this build, so the pipeline used a safer fallback.
analysis based solely on abstract; exact zoning facility definitions remain unverified
Where it stands
Introduced
CurrentPublic Law 144
Committee
UpcomingFloor
UpcomingGovernor
UpcomingEnacted
UpcomingHow it affects your district
Set your location
Add your district to see how this bill may affect your community and who to contact.
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.